<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
xmlns:content="http://purl.org/rss/1.0/modules/content/"
xmlns:wfw="http://wellformedweb.org/CommentAPI/"
xmlns:dc="http://purl.org/dc/elements/1.1/"
xmlns:atom="http://www.w3.org/2005/Atom"
xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
>
<channel>
	<title>ThaiPR.NET</title>
	<atom:link href="https://www.thaipr.net/location/jena-germany/feed" rel="self" type="application/rss+xml" />
	<link>https://www.thaipr.net/location/jena-germany</link>
	<description>Press Release Distribution Center of Thailand</description>
	<lastBuildDate>Wed, 22 Apr 2026 17:18:21 +0700</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.1.1</generator>
	<item>
		<title><![CDATA[Well Begun AND Half Done! – SIRONA Randomized Trial Achieves fifty percent enrollment]]></title>
		<link>https://www.thaipr.net/en/health_en/3155163</link>
		<dc:creator><![CDATA[thaipr.net]]></dc:creator>
		<pubDate>Fri, 11 Feb 2022 08:00:00 +0700</pubDate>
				<category>health_en</category>
		<guid isPermaLink="false">https://www.thaipr.net/en/health_en/3155163</guid>

					<description><![CDATA[<p>Concept Medical Inc., focused on vascular intervention drug delivery devices, releases the second status update of SIRONA RCT (Head-to-Head Comparison of SIROlimus versus Paclitaxel Drug-Eluting BallooNAngioplasty in the Femoropopliteal Artery), as the trial completes half the targeted enrolment. SIRONA is the world&#8217;s first and the largest head-to-head RCT investigating the use of Sirolimus DCB (Magic Touch PTA – Concept [&#8230;]</p>
<p>The post <a rel="nofollow" href="https://www.thaipr.net/en/health_en/3155163">Well Begun AND Half Done! – SIRONA Randomized Trial Achieves fifty percent enrollment</a> appeared first on <a rel="nofollow" href="https://www.thaipr.net">ThaiPR.NET</a>.</p>
]]></description>
									</item>
		<item>
		<title><![CDATA[SIRONA &#8211; The world&#8217;s first and largest RCT comparing Sirolimus V/S Paclitaxel balloon for the treatment of Peripheral Arterial Disease progresses rapidly]]></title>
		<link>https://www.thaipr.net/en/health_en/3058460</link>
		<dc:creator><![CDATA[thaipr.net]]></dc:creator>
		<pubDate>Thu, 27 May 2021 08:40:09 +0700</pubDate>
				<category>health_en</category>
		<guid isPermaLink="false">https://www.thaipr.net/en/health_en/3058460</guid>

					<description><![CDATA[<p>Concept Medical Inc., focused on vascular intervention drug delivery devices, releases status updates of SIRONA Randomized Control Trial (RCT) which compares head-to-head, SIROlimus versus Paclitaxel Drug-Eluting BallooNAngioplasty in femoropopliteal arterial diseases (SIRONA). SIRONA is the world&#8217;s first RCT investigating the use of Sirolimus drug coated balloon (DCB) (MagicTouch PTA – Concept Medical) V/S Paclitaxel DCB for the treatment of femoropopliteal [&#8230;]</p>
<p>The post <a rel="nofollow" href="https://www.thaipr.net/en/health_en/3058460">SIRONA &#8211; The world&#8217;s first and largest RCT comparing Sirolimus V/S Paclitaxel balloon for the treatment of Peripheral Arterial Disease progresses rapidly</a> appeared first on <a rel="nofollow" href="https://www.thaipr.net">ThaiPR.NET</a>.</p>
]]></description>
									</item>
	</channel>
</rss>
